Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Light Stimulation to Help Vision After Optic Neuritis in Multiple Sclerosis

Tests flicker light stimulation to improve vision in people with multiple sclerosis after optic neuritis.

Plain-language title generated from the registry record
Registry title: Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis

Key facts

Where
Munich, GermanySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Source: NCT06389968, who can take part

Where in Germany

  • Technical University of MunichMunich, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Technical University of Munich
Trial code
NCT06389968
Record updated
22 November 2024
Original description
The aim of this monocentric randomized controlled intervention study is to improve visual function in persons with multiple sclerosis following optic neuritis (neuritis nervi optici) by means of a light stimulation.Read full original descriptionShow less

Lichtstimulation Zur Verbesserung Der Sehleistung Bei Patientinnen Und Patienten Mit Multipler Sklerose Nach Sehnerventzündung

The aim of this monocentric randomized controlled intervention study is to improve visual function in persons with multiple sclerosis following optic neuritis (neuritis nervi optici) by means of a light stimulation.

In the treatment arm, two 80-second light stimulations are to be administered daily for 12 days in 25 persons with multiple sclerosis following recent optic neuritis (1-3 months). For the standardized application of light stimulation in the sense of standardized training, the light stimulation is to be carried out by watching a generated flicker video on a mobile phone. In a sham-intervened control group (sample size 25), the spontaneous course after optic neuritis will be recorded in parallel. Intensive neuronal stimulation of the visual pathway will be used to stimulate regenerative processes, which will be recorded by means of changes in high-contrast visual acuity (primary endpoint). Secondary endpoints are changes in a colored-contrast test, in 2.5% low contrast visual acuity, the peak conduction latency of visual evoked potentials, and retinal layer thicknesses and vessel densities measured in optical coherence tomography and optical coherence tomorgraphic angiography. These physiological parameters should help to understand the underlying processes of a potentially altered visual performance.

Inclusion: Relapsing remitting multiple sclerosis or clinically isolated syndrome or no indication of chronic inflammatory central nervous system disease; Age 18-60 years; Optic neuritis within 1-3 months.

Exclusion: Epilepsy; Retinal disease (glaucoma, macular edema, macula degeneration, ...); Light-triggered migraine; Insufficient vision correction.

ClinicalTrials.gov NCT06389968